Evidence map›Paper›PMID 35477117›Full record

ArticleBlood advances2022

Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder.

Aram Niaz, Jia Truong, Annabel Manoleras, Lucy C Fox, Piers Blombery, Raja S Vasireddy, Hilda A Pickett, Julie A Curtin, Pasquale M Barbaro, Jonathan Rodgers and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Clonal Signatures of Telomere Biology Disorders.Current hematologic malignancy reports · 2026
    Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Aram NiazRare Diseases Functional Genomics, Kids Research, The Children's Hospital at Westmead and Children's Medical Research Institute, Westmead, NSW, Australia.ORCID 0000-0001-6636-2555
Jia TruongSchool of Science, STEM (Science, Technology, Engineering, and Mathematics) College, Royal Melbourne Institute of Technology (RMIT), Bundoora, VIC, Australia.ORCID 0000-0002-7328-189X
Annabel ManolerasChildren's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.
Lucy C FoxDepartment of Pathology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.ORCID 0000-0002-3855-8232
Piers BlomberyDepartment of Pathology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Raja S VasireddyHaematology Department, Children's Hospital at Westmead, Westmead, NSW, Australia.ORCID 0000-0003-2849-4981
Hilda A PickettChildren's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.ORCID 0000-0002-9840-4841
Julie A CurtinHaematology Department, Children's Hospital at Westmead, Westmead, NSW, Australia.
Pasquale M BarbaroChildren's Health Queensland and University of Queensland, South Brisbane, QLD, Australia.ORCID 0000-0002-2628-9653
Jonathan RodgersGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia; and.ORCID 0000-0003-0760-8943
John RoyChildren's Health Queensland and University of Queensland, South Brisbane, QLD, Australia.ORCID 0000-0002-0898-8266
Lisa G RileyRare Diseases Functional Genomics, Kids Research, The Children's Hospital at Westmead and Children's Medical Research Institute, Westmead, NSW, Australia.
Jessica K HolienSchool of Science, STEM (Science, Technology, Engineering, and Mathematics) College, Royal Melbourne Institute of Technology (RMIT), Bundoora, VIC, Australia.ORCID 0000-0002-8735-2871
Scott B CohenChildren's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.
Tracy M BryanChildren's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia.ORCID 0000-0002-7990-5501
The University of Sydney · AUChildren's Hospital at Westmead · AURMIT University · AUThe University of Queensland · AUChildren's Medical Research Institute · AURoyal Brisbane and Women's Hospital · AUThe Royal Melbourne Hospital · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomere biology disorders (TBDs) are a spectrum of multisystem inherited disorders characterized by bone marrow failure, resulting from mutations in the genes encoding telomerase or other proteins involved in maintaining telomere length and integrity. Pathogenicity of variants in these genes can be hard to evaluate, because TBD mutations show highly variable penetrance and genetic anticipation related to inheritance of shorter telomeres with each generation. Thus, detailed functional analysis of newly identified variants is often essential. Herein, we describe a patient with compound heterozygous variants in the TERT gene, which encodes the catalytic subunit of telomerase, hTERT. This patient had the extremely severe Hoyeraal-Hreidarsson form of TBD, although his heterozygous parents were clinically unaffected. Molecular dynamic modeling and detailed biochemical analyses demonstrate that one allele (L557P) affects association of hTERT with its cognate RNA component hTR, whereas the other (K1050E) affects the binding of telomerase to its DNA substrate and enzyme processivity. Unexpectedly, the data demonstrate a functional interaction between the proteins encoded by the two alleles, with wild-type hTERT rescuing the effect of K1050E on processivity, whereas L557P hTERT does not. These data contribute to the mechanistic understanding of telomerase, indicating that RNA binding in one hTERT molecule affects the processivity of telomere addition by the other molecule. This work emphasizes the importance of functional characterization of TERT variants to reach a definitive molecular diagnosis for patients with TBD, and, in particular, it illustrates the importance of analyzing the effects of compound heterozygous variants in combination, to reveal interallelic effects.

Indexed as

TelomeraseBiologyHumansMutationRNATelomereRNATelomeraseTERT protein, human

Identifiers

PMID35477117
PMCPMC9631560
OpenAlexW4225009082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.